amrubicin
Showing 1 - 14 of 14
Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)
Not yet recruiting
- Small Cell Lung Cancer (SCLC)
- Tarlatamab
- +3 more
- (no location specified)
Feb 21, 2023
Advanced Solid Tumors Trial in United States (Amrubicin)
Completed
- Advanced Solid Tumors
- Amrubicin
-
La Jolla, California
- +7 more
Oct 30, 2019
Small Cell Lung Cancer Trial in Worldwide (Amrubicin, Cisplatin, Etoposide)
Completed
- Small Cell Lung Cancer
- Amrubicin
- +2 more
-
Antwerpen, Belgium
- +24 more
Nov 14, 2019
Small Cell Lung Cancer Trial in Netherlands, United Kingdom, United States (Amrubicin)
Completed
- Small Cell Lung Cancer
- Amrubicin
-
Phoenix, Arizona
- +45 more
Oct 16, 2019
Lung Cancer Trial in Worldwide (Nivolumab, Topotecan, Amrubicin)
Multiple Myeloma Trial in Stanford (Amrubicin, Lenalidomide, Dexamethasone)
Completed
- Multiple Myeloma
- Amrubicin
- +4 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 17, 2018
Extensive-Stage Small Cell Lung Cancer Trial in United States (Amrubicin, Carboplatin, Pegfilgrastim)
Completed
- Extensive-Stage Small Cell Lung Cancer
- Amrubicin
- +2 more
-
Jonesboro, Arkansas
- +19 more
Apr 1, 2016
Metastatic Breast Cancer Trial in United States (Amrubicin)
Withdrawn
- Metastatic Breast Cancer
- Amrubicin
-
New Milford, Connecticut
- +27 more
Sep 22, 2008